Evidence map›Paper›PMID 37947667›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Harnessing Nuclear Energy to Gold Nanoparticles for the Concurrent Chemoradiotherapy of Glioblastoma.

Jui-Ping Li, Yu-Cheng Kuo, Wei-Neng Liao, Ya-Ting Yang, Sih-Yu Chen, Yu-Ting Chien, Kuo-Hung Wu, Mei-Ya Wang, Fong-In Chou, Mo-Hsiung Yang and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Jui-Ping LiInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan.
Yu-Cheng KuoDepartment of Radiation Oncology, China Medical University Hospital, Taichung 40447, Taiwan.
Wei-Neng LiaoInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan.
Ya-Ting YangInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan.
Sih-Yu ChenInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan.
Yu-Ting ChienInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan.
Kuo-Hung WuNuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu 30013, Taiwan.
Mei-Ya WangNuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu 30013, Taiwan.ORCID 0000-0002-1130-9543
Fong-In ChouNuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu 30013, Taiwan.
Mo-Hsiung YangDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 30013, Taiwan.
Dueng-Yuan HuengSchool of Medicine, National Defense Medical Center, Taipei 11490, Taiwan.ORCID 0000-0001-7868-3161
Chung-Shi YangInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan.
Jen-Kun ChenInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan.ORCID 0000-0002-3433-5971
National Health Research Institutes · TWNational Tsing Hua University · TWChina Medical University · TWNational Chung Hsing University · TWNational Defense Medical Center · TW

Funding

National Health Research Institutes NM-100-PP11, NM-101-PP-11, and NM-102-PP-11National Science and Technology Council 101-2113-M-400-001-MY3 and 108-2113-M-400-002
6 · The paper itself

Abstract

Nuclear fission reactions can release massive amounts of energy accompanied by neutrons and γ photons, which create a mixed radiation field and enable a series of reactions in nuclear reactors. This study demonstrates a one-pot/one-step approach to synthesizing radioactive gold nanoparticles (RGNP) without using radioactive precursors and reducing agents. Trivalent gold ions are reduced into gold nanoparticles (8.6-146 nm), and a particular portion of

Indexed as

198Auconcurrent chemoradiotherapyglioblastomanuclear energyone-pot/one-step reactionradioactive gold nanoparticlestemozolomide

Identifiers

PMID37947667
PMCPMC10650840
OpenAlexW4387902904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.